Phase II trials of erlotinib or gefitini
โ
Andrew D. Norden; Jeffrey J. Raizer; Lauren E. Abrey; Kathleen R. Lamborn; Andre
๐
Article
๐
2009
๐
Springer US
๐
English
โ 263 KB